Plasmodium vivax infection in Anajás, State of Pará: No differential resistance profile among Duffy-negative and Duffy-positive individuals

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Carvalho, Tarcisio A A ^a   Queiroz, Maíse G ^a   Cardoso, Greice L ^a   Diniz, Isabela G ^a   Silva, Aylla N L M ^a   Pinto, Ana Y N ^b   Guerreiro, João F ^a  

^a Instituto de Ciencias Biologicas   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Brazilian Amazonia; Duffy blood group; Vivax malaria

Indexed keywords

DUFFY BINDING PROTEIN;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD GROUP DUFFY SYSTEM; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; GENE FREQUENCY; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MICROSCOPY; MITOCHONDRIAL GENOME; NONHUMAN; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BRAZIL; CROSS-SECTIONAL STUDIES; DNA; DUFFY BLOOD-GROUP SYSTEM; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOST-PARASITE INTERACTIONS; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM VIVAX;

EID: 84871382847     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-430     Document Type: Article

References (29)

1. Malaria in Brazil: an overview. Oliveira-Ferreira J, Lacerda MVG, Brasil P, Ladislau JLB, Tauil PL, Daniel-Ribeiro CT, Malar J 2010 115 115 128
2. Ministério da Saúde, Sistema de Informação e Vigilância Epidemiológica da Malária. SIVEP/Malária http://portalweb04.saude.gov.br/sivep-malaria/default.asp
3. Plasmodium vivax and the Duffy antigen: A paradigm revisited. Mercereau-Puijalon O, Ménard D, Transfus Clin Biol 2010 17 176 183 10.1016/j.tracli.2010.06.005 20655790
4. Speculations on the origins of Plasmodium vivax malaria. Carter R, Trends Parasitol 2003 19 214 219 10.1016/S1471-4922(03)00070-9 12763427 (Pubitemid 36588595)
5. Plasmodium vivax in Africa: hidden in plain sight? Rosenberg R, Trends Parasitol 2007 23 193 196 10.1016/j.pt.2007.02.009 17360237 (Pubitemid 46618122)
6. The global distribution of the Duffy blood group. Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ, Hay SI, Nat Commun 2011 2 266 21468018
7. Probable assignment of the Duffy blood group locus to chromosome 1 in man. Donahue RP, Bias WB, Renwick JH, McKusick VA, Proc Natl Acad Sci USA 1968 61 949 955 10.1073/pnas.61.3.949 5246559
8. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO, Blood 1995 85 615 621 7833466
9. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Iwamoto S, Omi T, Kajii E, Ikemoto S, Blood 1995 85 622 626 7833467
10. Mutation in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ, Brit J Hematol 1995 90 823 829 10.1111/j.1365-2141.1995.tb05202.x
11. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y, Hum Genet 1995 95 407 410 7705836
12. The Duffy protein: a malarial and chemokine receptor. Pogo AO, Chaudhuri A, Semin Hematol 2000 37 122 129 10.1016/S0037-1963(00)90037-4 10791881 (Pubitemid 30211151)
13. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individual. Tournamille C, Colin Y, Cartron JP, Kim CLV, Nat Genet 1995 10 224 228 10.1038/ng0695-224 7663520
14. Emergence of FY*A (null) in a Plasmodium vivax-endemic region of Papua New Guinea. Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara DT, Hazlett F, Mgone CS, Alpers MP, Genton B, Kazura JW, Proc Natl Acad Sci USA 1999 96 13973 13977 10.1073/pnas.96.24.13973 10570183
15. Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. Kasehagen LJ, Mueller I, Kiniboro B, Bockarie MJ, Reeder JC, Kazura JW, Kastens W, McNamara DT, King CH, Whalen CC, Zimmerman PA, PLoS One 2007 2 336 10.1371/journal.pone.0000336
16. Evidence for transmission of Plasmodium vivax among a Duffy antigen negative population in Western Kenya. Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, Owour B, Luckhart S, Wirtz RA, Barnwell JW, Rosenberg R, Am J Trop Med Hyg 2006 75 575 581 17038676 (Pubitemid 46941258)
17. Plasmodium vivax infection among Duffy antigen negative individuals from the Brazilian Amazon region: an exception? Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Valencia SH, Neiras WC, Alves RT, Rossit AR, Castilho L, Machado RL, Trans R Soc Trop Med Hyg 2007 101 1042 1044 10.1016/j.trstmh.2007. 04.011 17604067 (Pubitemid 47336851)
18. Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Valencia SH, Neiras WC, Alves RT, Rossit AR, Castilho L, Machado RL, Malar J 2007 6 167 10.1186/1475-2875-6-167 18093292 (Pubitemid 351255508)
19. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray R, Ratsimbasoa A, Thoniera V, Carodf JF, Domarlea O, Coling Y, Bertrandg O, Picotg J, King CL, Grimbergc BT, Mercereau-Puijalonb O, Zimmerman PA, Proc Natl Acad Sci USA 2010 107 5967 5971 10.1073/pnas.0912496107 20231434
20. Duffy negative antigen is no longer a barrier to Plasmodium vivax-molecular evidences from the African West Coast (Angola and Equatorial Guinea). Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, Sousa B, Rosário VE, Benito A, Berzosa P, Arez AP, PLoS Negl Trop Dis 2011 5 1192 10.1371/journal.pntd.0001192 21713024
21. Vivax malaria in Mauritania includes infection of a Duffy-negative individual. Wurtz N, Lekweiry KM, Bogreau H, Pradines B, Rogier C, Boukhary AOMS, Hafid JE, Salem MSOA, Trape JF, Basco LK, Briolant S, Malar J 2011 10 336 10.1186/1475-2875-10-336 22050867
22. Doenças de A a Z, 2010 http://portal.saude.gov.br/portal/saude/ profissional/areacfm?id-area=1526
23. Manual de diagnóstico laboratorial da malária 2005 http://portal.saude.gov.br/portal/arquivos/pdf/manual-diagnostico-malaria.pdf
24. A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL, Transfusion 1998 38 168 173 10.1046/j.1537-2995.1998.38298193099.x 9531948 (Pubitemid 28145083)
25. Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. King CL, Adams JH, Xianli J, Grimberg BT, McHenry AM, Greenberg LJ, Siddiqui A, Howes RE, da Silva-Nunes M, Ferreira MU, Zimmerman PA, Proc Natl Acad Sci USA 2011 108 20113 20118 10.1073/pnas.1109621108 22123959
26. Duffy blood group genotypes among African Brazilian communities of the Amazon region. Perna SJQ, Cardoso GL, Guerreiro JF, Genet Mol Res 2007 6 166 172 17469066 (Pubitemid 46740513)
27. Duffy blood group genotypes among malaria patients in Rondônia, Western Brazilian Amazon. Cavasini CE, Pereira FJT, Ribeiro WL, Wunderlich G, Ferreira MU, Rev Soc Bra Med Trop 2001 34 591 595 10.1590/S0037- 86822001000600016
28. FY polymorphisms and vivax malaria in inhabitants of Amazonas State, Brazil. Albuquerque SRL, Cavalcante FO, Sanguino EC, Tezza L, Castilho FCL, Santos MC, Parasitol Res 2010 106 1049 1053 10.1007/s00436-010-1745-x 20162434
29. The Amazon microcosm